8/19/2025Innovent Presents Phase 2 Study of Tarlatamab in Third-Line ES-SCLC at...

8/19/2025China Unveils Nine Key Healthcare Insurance Priorities for 2025

8/19/2025CSPC Pharma Advances in Biosimilars with Dupilumab Injection Approval

8/19/2025Eisai Launches First Orexin Receptor Antagonist for Insomnia in China

8/19/2025U.S. Tariffs Pressure Mounting, Japanese Pharma Looks East for Growth ...

8/19/2025Leaving China Manufacturing: The Hidden Risks And How To Protect Your ...

8/18/2025Tarlatamab Shows Promising Results in Chinese Phase 2 Trial for Heavil...

8/18/2025Pleryon Completes First Closing of Series A Financing

8/15/2025NHSA Issues Interim Measures for Disease-Based Medical Insurance Payme...

8/14/2025Amphastar Strikes Major Licensing Deal to Supercharge Peptide Pipeline

8/14/2025YolTech Unveils Breakthru In Vivo Editing of Human Blood Stem Cells

8/14/2025Remegen's Telitacicept Achieves Phase III Success

8/14/2025CDE Solicits Comments on Draft ICH M4Q(R2) Guidelines for Drug Qualit...

8/13/2025Merck Halts NSCLC Development of MK-1308 Amid Partnership with China's...

8/13/2025NHSA Publishes Preliminary Review Results for 2025 NRDL Adjustments wi...

8/13/2025Summit Skips Quarterly Earnings Call amid Strategic Shifts and BLA Pla...

8/13/2025MNCs Target China's New Commercial Insurance Catalog to Gain Ground

8/12/2025Akeso Doses First Patient in Phase III Trial of Ivonescimab

8/11/2025Novo Nordisk Reports Solid Growth in China Amid Global Expansion in H1...

8/8/2025Minghui's MHB042C Earns Green Light for Clinical Trials in Advanced So...

8/8/2025AstraZeneca Expands Use of Fasenra in China

8/8/2025Minghui Raises $131M to Accelerate Clinical and Commercial Expansion

8/8/2025Shanghai Unveils 18 New Measures to Boost Commercial Health Insurance ...

8/8/2025Triple Squeeze Threatens China's Global Drug Push

8/8/2025Hengrui Launches Phase 3 Trial of Trastuzumab Rezetecan Combo for AGC

8/8/2025Wuxi Apptec Strengthens European Foothold with Luxembourg Expansion Am...

8/8/2025Recent Executive Moves

8/8/2025Pharma MNCs in China H1/2025 – Mature Products Exit, Top Performers R...

8/8/2025China Biopharma Tracker – July 2025: Funding Surges and Major Deals (...

8/7/2025Innovation through Talent: How Leadership Is Evolving in China's Life ...

Page:11/375 Total number of articles:11230: [First][<<] [9] [10] [11] [12] [13] [>>] [End]